Sponsor Pipeline

Chengdu New Radiomedicine Technology Co. LTD. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06900543 Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere Unresectable Hepatocellular Carcinoma Active, Not Recruiting
Phase 1
NCT06911489 Safety Trial of 68Ga/177Lu-NRT6020 in FAP-Positive Advanced Solid Tumor Patients Solid Tumor Malignancy Recruiting
NCT06278454 Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic… Unresectable Pancreatic Cancer Recruiting
Disease Areas
Pancreatic Cancer (1) Liver Cancer (1)
Get alerts when Chengdu New Radiomedicine Technology Co. LTD.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free